VMP 41772111000001108

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Trastuzumab 150mg powder for solution for infusion vials
BNF code 0801050ADAAAAAA
Virtual Therapeutic Moiety Trastuzumab
Date identifier became valid 9 May 2023
Previous product identifier 327399009
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 15 Jan 2009
Previous name Trastuzumab 150mg powder for solution for injection vials
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Caution - AMP level prescribing advised
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units vial
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Trastuzumab
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 150.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Dose Form
Formulation Powder for solution for infusion
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Herceptin 150mg powder for concentrate for solution for infusion vials (Roche Products Ltd)
Herzuma 150mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
Kanjinti 150mg powder for concentrate for solution for infusion vials (Amgen Ltd)
Ontruzant 150mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd)
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord-UK Ltd)
Virtual Medicinal Product Packs
Trastuzumab 150mg powder for solution for infusion vials 1 vial

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback